| __timestamp | Lantheus Holdings, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 15635076 |
| Thursday, January 1, 2015 | 14358000 | 23943601 |
| Friday, January 1, 2016 | 12203000 | 23689111 |
| Sunday, January 1, 2017 | 18125000 | 41006114 |
| Monday, January 1, 2018 | 17071000 | 51379106 |
| Tuesday, January 1, 2019 | 20018000 | 32705593 |
| Wednesday, January 1, 2020 | 32788000 | 53274000 |
| Friday, January 1, 2021 | 44966000 | 85352000 |
| Saturday, January 1, 2022 | 311681000 | 51999000 |
| Sunday, January 1, 2023 | 77707000 | 59471000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology and pharmaceuticals, innovation is the key to staying ahead. Over the past decade, Summit Therapeutics Inc. and Lantheus Holdings, Inc. have been at the forefront of this race. From 2014 to 2023, Summit Therapeutics consistently increased its R&D spending, peaking in 2021 with an impressive 85% growth compared to 2014. Meanwhile, Lantheus Holdings made a significant leap in 2022, with a staggering 1,200% increase in R&D expenses from its 2014 levels. This surge underscores Lantheus's commitment to innovation, particularly in recent years. While Summit's investment strategy shows steady growth, Lantheus's dramatic increase in 2022 highlights a strategic pivot towards aggressive innovation. As these companies continue to invest in research and development, the future of medical advancements looks promising.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.